NRG1 and neoplasm: The results showed that the levels of serum NRG1 (Fig. 1A), NRG1 protein in tumor tissues (Fig. 1B) and NRG1 mRNA in tumor tissue (Fig. 1C), were all significantly higher in CRPC patients before receiving ADT treatment, compared to NCRPC patients.